These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38809874)

  • 61. Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome.
    Witsil JC; Mycyk MB
    Am J Ther; 2017; 24(1):e64-e67. PubMed ID: 25393073
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of Recreational Cannabis Legalization on Hospitalizations for Hyperemesis.
    Nemer L; Lara LF; Hinton A; Conwell DL; Krishna SG; Balasubramanian G
    Am J Gastroenterol; 2021 Mar; 116(3):609-612. PubMed ID: 33657044
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting.
    Smith TN; Walsh A; Forest CP
    JAAPA; 2019 Apr; 32(4):1-5. PubMed ID: 30913155
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cannabis use and cyclical vomiting syndrome: An open debate.
    Kilani Y; Aljabiri Y; Arshad I; Alsakarneh S; Aldiabat M; Castro Puello P; Vahanyan A; Vikash F; Kumar V; Numan L; Thor S
    Dig Liver Dis; 2024 Feb; 56(2):272-280. PubMed ID: 37880016
    [TBL] [Abstract][Full Text] [Related]  

  • 65. "I still partly think this is bullshit": A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting.
    Collins AB; Beaudoin FL; Metrik J; Wightman RS
    Drug Alcohol Depend; 2023 May; 246():109853. PubMed ID: 36996524
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Diagnosis of cannabinoid hyperemesis : update on the cannabis-shower syndrome].
    Cuppens B; Gensburger M; Tonglet M; Marissiaux L; Brasseur E; d'Orio V; Ghuysen A
    Rev Med Liege; 2016 Dec; 71(12):541-545. PubMed ID: 28387093
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cannabinoid Hyperemesis Syndrome in an Athlete.
    Fleshman B; Kaiser K
    J Am Board Fam Med; 2021; 34(4):811-813. PubMed ID: 34312273
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Trends and Related Factors of Cannabis-Associated Emergency Department Visits in the United States: 2006-2014.
    Shen JJ; Shan G; Kim PC; Yoo JW; Dodge-Francis C; Lee YJ
    J Addict Med; 2019; 13(3):193-200. PubMed ID: 30418337
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reply to Letter "Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome".
    Senderovich H; Patel P; Jimenez Lopez B; Waicus S
    Med Princ Pract; 2022; 31(5):499-500. PubMed ID: 35817006
    [No Abstract]   [Full Text] [Related]  

  • 70. Cannabinoid hyperemesis syndrome and cannabis withdrawal syndrome: a review of the management of cannabis-related syndrome in the emergency department.
    Razban M; Exadaktylos AK; Santa VD; Heymann EP
    Int J Emerg Med; 2022 Sep; 15(1):45. PubMed ID: 36076180
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
    Bajgoric S; Samra K; Chandrapalan S; Gautam N
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [A patient with acute abdominal pain and vomiting due to the cannabinoid hyperemesis syndrome].
    Blanken MAJT; Peeters FPML
    Tijdschr Psychiatr; 2020; 62(1):73-77. PubMed ID: 31994714
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study.
    Pélissier F; Claudet I; Gandia-Mailly P; Benyamina A; Franchitto N
    J Emerg Med; 2016 Nov; 51(5):544-551. PubMed ID: 27485997
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.
    Lee A; Coralic Z
    Ann Pharmacother; 2022 Feb; 56(2):151-154. PubMed ID: 33998315
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical and financial implications of emergency department visits for synthetic marijuana.
    Rowley E; Benson D; Tiffee A; Hockensmith A; Zeng H; Jones GN; Musso MW
    Am J Emerg Med; 2017 Oct; 35(10):1506-1509. PubMed ID: 28457767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study.
    McCarthy SDS; Xiao J; Pugliese M; Perrault-Sequeira L; Myran DT
    Lancet Reg Health Am; 2024 Aug; 36():100815. PubMed ID: 38974381
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mental Health Conditions- and Substance Use-Associated Emergency Department Visits during the COVID-19 Pandemic in Nevada, USA.
    Mojtahedi Z; Guo Y; Kim P; Khawari P; Ephrem H; Shen JJ
    Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901398
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis.
    Pourmand A; Esmailian G; Mazer-Amirshahi M; Lee-Park O; Tran QK
    Am J Emerg Med; 2021 May; 43():35-40. PubMed ID: 33493995
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Cannabinoid hyperemesis syndromecan be relieved by hot showers].
    Søndermølle MB; Randers E
    Ugeskr Laeger; 2021 Apr; 183(15):. PubMed ID: 33913422
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin.
    Stumpf JL; Williams LD
    J Pharm Pract; 2021 Oct; 34(5):786-793. PubMed ID: 32613883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.